SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Straub RE, Jiang Y, MacLean CJ et al. Genetic variation in the 6p22.3 gene dtnbp1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet. 2002; 71: 337348.
  • 2
    Li T, Zhang F, Liu X et al. Identifying potential risk haplotypes for schizophrenia at the DTNBP1 locus in Han Chinese and Scottish populations. Mol. Psychiatry 2005; 10: 10371044.
  • 3
    Numakawa T, Yagasaki Y, Ishimoto T et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 2004; 13: 26992708.
  • 4
    Kirov G, Ivanov D, Williams NM et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol. Psychiatry 2004; 55: 971975.
  • 5
    Funke B, Finn CT, Plocik AM et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am. J. Hum. Genet. 2004; 75: 891898.
  • 6
    Williams NM, Preece A, Morris DW et al. Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1). Arch. Gen. Psychiatry 2004; 61: 336344.
  • 7
    Van Den Oord EJ, Sullivan PF, Jiang Y et al. Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1) gene in the Irish study of high-density schizophrenia families. Mol. Psychiatry 2003; 8: 499510.
  • 8
    Van Den Bogaert A, Schumacher J, Schulze TG et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet. 2003; 73: 14381443.
  • 9
    Tang JX, Zhou J, Fan JB et al. Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol. Psychiatry 2003; 8: 717718.
  • 10
    Schwab SG, Knapp M, Mondabon S et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet. 2003; 72: 185190.
  • 11
    Tochigi M, Zhang X, Ohashi J et al. Association study of the dysbindin (DTNBP1) gene in schizophrenia from the Japanese population. Neurosci. Res. 2006; 56: 154158.
  • 12
    Joo EJ, Lee KY, Jeong SH, Ahn YM, Koo YJ, Kim YS. The dysbindin gene (DTNBP1) and schizophrenia: No support for an association in the Korean population. Neurosci. Lett. 2006; 407: 101106.
  • 13
    Holliday EG, Handoko HY, James MR et al. Association study of the dystrobrevin-binding gene with schizophrenia in Australian and Indian samples. Twin Res. Hum. Genet. 2006; 9: 531539.
  • 14
    Weickert CS, Rothmond DA, Hyde TM, Kleinman JE, Straub RE. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr. Res. 2008; 98: 105110.
  • 15
    Weickert CS, Straub RE, McClintock BW et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry 2004; 61: 544555.
  • 16
    Talbot K, Eidem WL, Tinsley CL et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 2004; 113: 13531363.
  • 17
    Chiba S, Hashimoto R, Hattori S et al. Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus. J. Neural. Transm. 2006; 113: 13371346.
  • 18
    Greenwood TA, Braff DL, Light GA et al. Initial heritability analyses of endophenotypic measures for schizophrenia: The consortium on the genetics of schizophrenia. Arch. Gen. Psychiatry 2007; 64: 12421250.
  • 19
    Weinberger DR, Egan MF, Bertolino A et al. Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatry 2001; 50: 825844.
  • 20
    Burdick KE, Lencz T, Funke B et al. Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet. 2006; 15: 15631568.
  • 21
    Burdick KE, Goldberg TE, Funke B et al. DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophr. Res. 2007; 89: 169172.
  • 22
    Donohoe G, Morris DW, Clarke S et al. Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study. Neuropsychologia 2007; 45: 454458.
  • 23
    Zinkstok JR, De Wilde O, Van Amelsvoort TA, Tanck MW, Baas F, Linszen DH. Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behav. Brain Funct. 2007; 3: 19.
  • 24
    Takao K, Toyama K, Nakanishi K et al. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol. Brain 2008; 1: 11.
  • 25
    Sugishita M. Japanese Wechsler Memory Scale–Revised. Nihonbunkakagakusha, Tokyo, 2001.
  • 26
    Wechsler D. Wechsler Memory Scale Manual–Revised. Psychological Corporation, San Antonio, TX, 1987.
  • 27
    Shinagawa F, Kobayashi S, Fujita K, Maekawa H. Japanese Wechsler Adult Intelligence Scale–Revised. Nihonbunkakagakusha, Tokyo, 1990.
  • 28
    Wechsler D. Wechsler Adult Intelligence Scale–Revised. Psychological Corporation, New York, 1981.
  • 29
    Hori H, Noguchi H, Hashimoto R et al. Antipsychotic medication and cognitive function in schizophrenia. Schizophr. Res. 2006; 86: 138146.
  • 30
    Chen XW, Feng YQ, Hao CJ et al. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J. Cell. Biol. 2008; 181: 791801.
  • 31
    Kumamoto N, Matsuzaki S, Inoue K et al. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem. Biophys. Res. Commun. 2006; 345: 904909.
  • 32
    Kubota K, Kumamoto N, Matsuzaki S et al. Dysbindin engages in c-Jun N-terminal kinase activity and cytoskeletal organization. Biochem. Biophys. Res. Commun. 2009; 379: 191195.
  • 33
    Hattori S, Murotani T, Matsuzaki S et al. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem. Biophys. Res. Commun. 2008; 373: 298302.
  • 34
    Murotani T, Ishizuka T, Hattori S, Hashimoto R, Matsuzaki S, Yamatodani A. High dopamine turnover in the brains of Sandy mice. Neurosci. Lett. 2007; 421: 4751.
  • 35
    Iizuka Y, Sei Y, Weinberger DR, Straub RE. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. J. Neurosci. 2007; 27: 12 39012 395.
  • 36
    Lewis DA, Gonzalez-Burgos G. Pathophysiologically based treatment interventions in schizophrenia. Nat. Med. 2006; 12: 10161022.